Strategic Initiatives Strategic Initiatives: In 2024, the company introduced MIMEDX Connect, an e-commerce and account management platform to streamline ordering and payment processes. It also entered into an exclusive agreement to commercialize HELIOGEN, a bovine-derived collagen matrix particulate for wound management, and published research on surgical applications of its placental-based allografts. Capital Management: The company improved its capital structure by entering into a new Credit Agreement with Citizens Bank, refinancing $50 million of senior secured term loans at lower interest rates, and securing additional borrowing capacity. It repaid $30 million of the initial drawing under the Revolving Credit Facility and had no borrowings outstanding as of December 31, 2024. The company also repurchased shares for tax withholdings upon vesting of employee awards and converted its Series B Preferred Stock into common stock.